tfos dews II report

DEWS II
COMMITTEES

Now that we have launched the TFOS DEWS II, we would like to thank the experts who are participating in this global initiative. Every week for a period of 12 weeks we will thank those individuals serving on one of the 12 different Subcommittees. The Subcommittee meetings begin in June in Paris. The members are...

> Steering Committee

> Definition & Classification Subcommittee

> Epidemiology Subcommittee

> Iatrogenic Dry Eye Disease Subcommittee

> Pathophysiology Subcommittee

> Sex, Hormones & Gender Subcommittee

> Management & Therapy Subcommittee

> Clinical Trials Subcommittee

> Tear Film Subcommittee

> Diagnosis Subcommittee

> Pain & Sensation Subcommittee

> Public Awareness & Education Subcommittee

Industry Liasion

Sullivan, David A (Chair; USA), Senior Scientist, Schepens Eye Research Institute & Massachusetts Eye and Ear, and Associate Professor, Harvard Medical School, Boston, MA

Ackerman, Michael (USA), President & Chief Executive Officer, Oculeve

Couderc, Chantal (France), Directeur des Affaires Médicales, Horus

Dempsey, Robert (USA), Vice President, Eye Care, Shire

Houtman, Diane (USA), Vice President, Professional Relations, Akorn

Jasek, Mark C (USA), Vice President of Medical and Scientific Affairs, Ophthalmic Business, Sun Pharma

Kern, Jami R (USA), Vision Care Franchise Head, Global Medical Affairs, Alcon

Koffler, Dawn (USA), Director, United States Strategic Marketing, Eye Care, Allergan

Mantelli, Flavio (Italy), Chief Medical Officer, United States Ophthalmology, Dompé

Mazzone, Maria Grazia (Italy) Head of Project Management, SIFI Pharma

Meyering, Robert J (USA), Vice President, Global Medical Relations and Operations, Bausch & Lomb

Purslow, Christine (UK), Head, Medical Affairs, UK & Ireland, Laboratoires Théa

Speed, Julie (USA), Vice President, Global Marketing, TearLab

Truitt, Edward R III (USA), CEO Lubris

Wilson, Tawnya J. (USA), Principal Research Optometrist, Johnson & Johnson Vision Care (JJVCI)

 

 

Alcon

Novartis

Shire

Allergan

Bausch + Lomb

Akorn

Cooper Vision

Dompè

Horus

lubris

Oculeve

Sun Pharma

TearLab

Thea

Sifi

for Johnson & Johnson Vision Care

DEWS II
MISSION & OBJECTIVES

TFOS DEWS II will update the definition, classification and diagnosis of dry eye disease, critically assess the etiology, mechanism, distribution and global impact of this disorder, and address its management and therapy.

read on

DEWS II
NEWS

The TFOS DEWS II™ Report Special Interest Group will occur at the ARVO Annual Meeting on Sunday, May 7, from 1:30 – 3:00 pm in Ballroom 4 of the Baltimore Convention Center. 

read on

DEWS II
NEWS

TFOS DEWS II will update the definition, classification and diagnosis of dry eye disease, critically assess the etiology, mechanism, distribution and global impact of this disorder, and address its management and therapy. This report will be published in The Ocular Surface and the TFOS DEWS II members...

read on

 


TFOS
TEAR FILM & OCULAR SURFACE SOCIETY

TFOS is a world leader in eye health education.

TFOS' global collaboration among scientists, clinicians and industry professionals seeks action needed to help the world see better.

read on

tfos twitter account tfos linked in accounttfos youtube accounttfos blog account
 
 
TFOS Dew Report Homepage News Tfos Dews Report Sponsors Tfos Dews Report Timeline Tfos Dews Report  Objectives Tfos Dews Report Committees Tfos Dews Report